MHLW Official Restates Difficulty of Moving Up Timeline to Attain 80% Generic Share

MHLW Official Katsufumi Jo (right)
Generic makers must be able to churn out a combined 100 billion tablets annually to achieve a proposed volume-based generic penetration target of 80% in FY2020, and it is difficult to move up this schedule as advocated by some people as a way to curb medical spending, a health ministry official said.

Generic makers are currently scrambling to expand their combined annual production capacity by roughly 28.5 billion tablets under an ongoing five year roadmap targeting 60% at the end of FY2017. With this addition, Japan will have a generic production system capable of supplying 72 billion tablets a year at the end of FY2017, according to Katsufumi Jo, director of the Economic Affairs Division at the Ministry of Health, Labor and Welfare’s (MHLW) Health Policy Bureau, who made a speech at an annual meeting of the Japan Society of Generic Medicines, held on June 13-14.

News Calendar